Skip to main content

Table 5 Comparison of baseline demographic and clinical characteristics between survivors and patients without six month follow-up

From: Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome

Parameter

Survivors

No 6-Month Follow-up

P-Value

Age (years)

N

92

293

 
 

Mean ± SD

46.4 ± 15.9

50.9 ± 17.4

0.044

 

Range

16.8 - 84.0

17.6 - 87.0

 

Sex, n (%)

Male

44 (47.8%)

161 (54.9%)

0.281

 

Female

48 (52.2%)

132 (45.1%)

 

Race, n (%)

Caucasian

77 (83.7%)

227 (77.5%)

0.423

 

Black

9 (9.8%)

44 (15.0%)

 
 

Other

6 (6.5%)

22 (7.5%)

 

Height (cm)

N

90

277

 
 

Mean ± SD

169.1 ± 10.2

169.2 ± 11.6

0.856

Weight (kg)

N

92

292

 
 

Mean ± SD

80.5 ± 21.9

79.4 ± 20.1

0.840

Causes of ARDS,a n (%)

    

Pneumonia

 

35 (38.0%)

142 (48.5%)

0.093

Toxic Gas Inhalation

 

0 (0%)

0 (0%)

1.000

Acute Pancreatitis

 

4 (4.3%)

12 (4.1%)

1.000

Masssive Blood Transfusion

 

15 (16.3%)

31 (10.6%)

0.144

Fat Emboli

 

3 (3.3%)

7 (2.4%)

0.708

Aspiration Pneumonitis

 

18 (19.6%)

72 (24.6%)

0.397

Pulmonary Contusion

 

18 (19.6%)

51 (17.4%)

0.642

Post-Partum ARDS

 

2 (2.2%)

1 (0.3%)

0.143

Multiple Trauma

 

29 (31.5%)

74 (25.3%)

0.280

Elective or Emergency Surgical Procedures

 

29 (31.5%)

100 (34.1%)

0.705

Patient History, n (%)

    

Preexisting steroid use

 

11 (12.0%)

34 (11.6%)

1.000

Asthma

 

9 (9.8%)

30 (10.2%)

1.000

COPD

 

12 (13.0%)

36 (12.3%)

0.857

Tobacco use

 

47 (51.1%)

121 (41.3%)

0.117

Other lung diseaseb

 

0 (0%)

18 (6.1%)

0.009

  1. aPatients may have more than one cause of ARDS. bPatients may have more than one preexisting disease including: cancer, bronchitis, amiodarone toxicity, and status/post lung resection. ARDS, acute respiratory distress; COPD, chronic obstructive pulmonary disorder; N, number; NO, nitric oxide.